Moreover, the increased EGFR protein levels in the tumour tissues of NSCLC patients and the decreased EGFR protein levels in xenograft tumours following EPN3 knockdown suggest that the ErbB signalling pathway may play a role in A549 cell proliferation and differentiation after EPN3 knockdown (Fig. 5C, D). The gene discussed is EGFR; the disease is neoplasm.